LSAK
Lesaka Technologies, Inc.
LSAK has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over LSAK overall, supported by stronger fundamentals and stronger modeled upside.
LSAK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Stable |
LSAK's revenue and profitability are currently healthy, and its cash flow and balance sheet are stable.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
LSAK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 111x | $3.32 | — |
| Cheap | 125x | $3.75 | +13% |
| Fair | 140x | $4.19 | +26% |
| Expensive | 146x | $4.39 | +32% |
Historical ranges are pointers, not guarantees.
LSAK has the edge over SNDK in the historical PE scenario, which offers more potential upside but is not a forecast.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
LSAK Forward outlook
There aren't enough analyst estimates for LSAK to show an outlook.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
LSAK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.03 | +$1.15 |
| Q2 2026 | $0.03 | +$1.17 |
| Q1 2026 | -$0.40 | +$0.42 |
| Q4 2025 | -$0.68 | -$0.07 |
| Q3 2025 | -$1.12 | -$0.87 |
| Q2 2025 | -$1.14 | -$0.87 |
| Q3 2022 | -$0.69 | -$0.30 |
| Q2 2022 | -$0.75 | -$0.08 |
LSAK has returned to profit: it earned $0.03 per share over the past year, after losing money the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over LSAK in the latest year-over-year earnings comparison.
LSAK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $184.6M | +7.7% |
| Q2 2026 | $188.3M | +12% |
| Q1 2026 | $183.1M | +13% |
| Q4 2025 | $178.7M | +1.4% |
| Q3 2025 | $171.4M | +12% |
| Q2 2025 | $168.5M | +15% |
| Q1 2025 | $161.5M | +17% |
| Q4 2024 | $176.2M | +22% |
LSAK's revenue has grown year over year for 19 quarters in a row: $185M last quarter, up 7.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.6% | -0.8 points |
| Q2 2026 | 3.4% | +20 points |
| Q1 2026 | 2.2% | +1.9 points |
| Q4 2025 | 1.2% | +0.8 points |
| Q3 2025 | 0.2% | +0.3 points |
| Q2 2025 | -17% | -17 points |
| Q1 2025 | 0.3% | -0.2 points |
| Q4 2024 | 0.4% | -1.1 points |
LSAK's operating margin was −0.6% last quarter, down 0.8 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over LSAK on profitability, with a higher operating margin.
LSAK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$15M | -404% |
| Q2 2026 | $7.5M | +$18.1M |
| Q1 2026 | $34.2M | +336% |
| Q4 2025 | -$14.8M | +$646K |
| Q3 2025 | $4.9M | +$13M |
| Q2 2025 | -$10.6M | -1229% |
| Q1 2025 | $7.8M | -52% |
| Q4 2024 | -$15.5M | -$13.9M |
LSAK's free cash flow has turned positive after six years mostly in the red: $12M over the past year.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
LSAK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.3x | Moderate |
| Q2 2026 | 2.2x | Moderate |
| Q1 2026 | 4.3x | High |
| Q4 2025 | 7.2x | High |
| Q3 2025 | 10.0x | High |
| Q2 2025 | 18.8x | High |
| Q1 2025 | 4.0x | High |
| Q4 2024 | 3.1x | Elevated |
LSAK's net debt is about 2.3 years of its operating earnings (EBITDA), down from 10 years a year ago.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has the edge over LSAK on leverage, with a lower net debt burden relative to earnings.
LSAK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.8 | Oversold |
| Stochastic | 5.2 | Oversold |
LSAK's weekly RSI is 28 (oversold) and its Stochastic is 5 (oversold).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
LSAK PE vs Technology Sector
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
LSAK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.07 | 18% below |
| 20 week MA | $4.40 | 25% below |
| 50 week MA | $4.58 | 28% below |
| 100 week MA | $4.56 | 27% below |
| 200 week MA | $4.39 | 24% below |
SNDK has stronger trend alignment. LSAK is above 0 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
LSAK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.74 | $4.74 | +27% |
| 2021 | $4.74 | $5.41 | +14% |
| 2022 | $5.41 | $3.79 | -30% |
| 2023 | $3.79 | $3.24 | -15% |
| 2024 | $3.24 | $5.25 | +62% |
| 2025 | $5.25 | $4.36 | -17% |
| 2026 YTD | $4.36 | $3.32 | -24% |
LSAK has finished lower in three of the last six years. It's down 24% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over LSAK on returns for 2026, with the stronger performance.